Glow Blend Peptide 70mg – Protide Health USA

Glow Blend Peptide Overview & Technical Specifications

The Glow Blend peptide is a three-component laboratory research formulation containing:

• GHK-Cu: 50mg
• BPC-157: 10mg
• TB-500 / Thymosin Beta-4: 10mg
• Total Research Material: 70mg

The Glow Blend combines three chemically distinct peptide systems in one 3mL vial:

• A copper-binding tripeptide complex
• A synthetic 15-amino-acid peptide
• A full-length 43-amino-acid actin-binding peptide

Protide Health supplies the Glow Blend peptide as 99% purity, HPLC-MS verified, third-party tested lyophilized research material for biochemical, cellular, molecular, analytical, in-vitro, and qualified preclinical investigation.

Technical Specifications

• Product Name: Glow Blend
• Alternative Names: Glow Peptide, Glow Peptide Blend, GHK-Cu BPC-157 TB-500 Blend
• Total Quantity: 70mg
• GHK-Cu: 50mg
• BPC-157: 10mg
• TB-500 / Thymosin Beta-4: 10mg
• Form: Lyophilized powder
• Vial Size: 3mL
• Purity: 99%
• Testing: HPLC-MS verified; third-party tested
• Appearance: Blue to blue-white lyophilized material
• Solubility: Soluble in water
• Storage: Store sealed at ≤6°C and protected from heat, light, and moisture
• Research Classification: Laboratory and qualified preclinical research only

Glow Blend Peptides: Component Overview

The individual Glow Blend peptides should be treated as separate molecular entities.

GHK-Cu — 50mg

GHK-Cu is the copper complex of:

Gly-His-Lys

or:

GHK

The supplied Cu-GHK representation is:

• PubChem CID: 378611
• Molecular Formula: C14H24CuN6O4
• Molecular Weight: approximately 403.93 g/mol
• Peptide Sequence: Gly-His-Lys
• Metal Component: Copper

Researchers can review the supplied GHK-Cu chemical structure.

GHK-Cu Identifier Clarification

The supplied CAS number 49557-75-7 corresponds to metal-free GHK.

For prezatide copper / Copper Tripeptide-1, PubChem lists:

CAS 89030-95-5

The copper complex can appear in several database representations because of coordination state, protonation, charge, and stoichiometry.

For definitive characterization, researchers should rely on the actual lot-specific analytical documentation.

BPC-157 — 10mg

BPC-157 is a synthetic pentadecapeptide with the sequence:

Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val

or:

GEPPPGKPADDAGLV

Verified reference data include:

• PubChem CID: 9941957
• CAS Number: 137525-51-0
• Molecular Formula: C62H98N16O22
• Molecular Weight: approximately 1419.56 g/mol
• Peptide Length: 15 amino acids

Researchers can review the supplied BPC-157 chemical structure.

PubChem currently identifies BPC-157 with this same sequence, formula, molecular weight, and CAS number.

TB-500 / Thymosin Beta-4 — 10mg

The supplied Glow Blend specification defines TB-500 as full-length N-acetylated thymosin beta-4.

Its sequence is:

Ac-Ser-Asp-Lys-Pro-Asp-Met-Ala-Glu-Ile-Glu-Lys-Phe-Asp-Lys-Ser-Lys-Leu-Lys-Lys-Thr-Glu-Thr-Gln-Glu-Lys-Asn-Pro-Leu-Pro-Ser-Lys-Glu-Thr-Ile-Glu-Gln-Glu-Lys-Gln-Ala-Gly-Glu-Ser

or:

Ac-SDKPDMAEIEKFDKSKLKKTETQEKNPLPSKETIEQEKQAGES-OH

Verified reference data include:

• PubChem CID: 16132341
• CAS Number: 77591-33-4
• Molecular Formula: C212H350N56O78S
• Molecular Weight: approximately 4963 g/mol
• Peptide Length: 43 amino acids

Researchers can review the supplied TB-500 / thymosin beta-4 chemical structure.

PubChem identifies CID 16132341 as full-length N-acetylated thymosin beta-4/timbetasin with the supplied 43-residue sequence.

Glow Blend Peptide Research Context

The Glow Blend peptide brings together three research compounds associated with distinct molecular pathways.

GHK-Cu Research Areas

Research involving GHK-Cu has examined:

• Copper coordination
• Fibroblast biology
• Extracellular-matrix remodeling
• Matrix metalloproteinases
• TIMP proteins
• Gene-expression changes
• Cell migration
• Oxidative-stress pathways

BPC-157 Research Areas

BPC-157 literature has examined:

• Vascular signaling
• VEGF-associated pathways
• FAK signaling
• Nitric-oxide systems
• Endothelial responses
• Experimental tissue-response models

TB-500 / Thymosin Beta-4 Research Areas

Thymosin beta-4 research has examined:

• G-actin binding
• Actin sequestration
• Cytoskeletal regulation
• Cell migration
• Endothelial biology
• Tissue-remodeling models

The Glow Blend peptides therefore span copper-peptide chemistry, vascular signaling, and actin-associated cellular biology.

GHK-Cu & Extracellular Matrix Research

One of the stronger direct research areas for GHK-Cu involves extracellular-matrix remodeling.

A fibroblast study found that GHK-Cu increased MMP-2 expression and also altered secretion of TIMP-1 and TIMP-2.

The researchers concluded that the copper-peptide complex influenced both connective-tissue production and matrix-remodeling processes.

This is important because GHK-Cu should not be reduced to a simple “collagen peptide” description.

Its experimental biology involves several interconnected matrix pathways.

BPC-157 & Vascular Research

BPC-157 research has included vascular-response models involving:

• Endothelium
• VEGF-associated signaling
• Nitric oxide
• FAK pathways
• Vasculogenesis
• Angiogenesis
• Arteriogenesis

A published review specifically discussed BPC-157 in relation to blood-vessel responses and highlighted proposed interactions with NO, VEGF, and FAK pathways.

Much of this evidence remains preclinical and should not be converted into human therapeutic claims.

TB-500 & Actin Research

Thymosin beta-4 has a well-characterized biochemical relationship with actin.

Experimental work demonstrated that thymosin beta-4 forms approximately 1:1 complexes with actin monomers and can inhibit actin polymerization by sequestering G-actin.

Structural research found that thymosin beta-4 interacts with regions at both the barbed and pointed ends of actin.

This makes actin dynamics one of the clearest mechanistic research pathways represented in the Glow Blend peptide.

Glow Blend Peptide Benefits: Evidence Context

The phrase glow blend peptide benefits commonly appears in consumer-oriented searches.

Individual components have been investigated in experimental systems involving:

• Extracellular-matrix biology
• Fibroblast signaling
• Cell migration
• Vascular responses
• Cytoskeletal regulation
• Actin dynamics
• Copper-dependent signaling
• Gene expression

However, these studies do not establish that the combined Glow Blend peptide:

• Improves skin appearance
• Produces cosmetic rejuvenation
• Treats wounds
• Accelerates recovery
• Enhances athletic performance
• Treats musculoskeletal injuries
• Provides anti-aging effects

The three-component formulation itself requires direct experimental study.

Recent reviews also emphasize that many emerging peptide products have far more preclinical than high-quality human safety and efficacy evidence.

Glow Peptide Blend & Combined Research

The term glow peptide blend describes the combination rather than a new single chemical entity.

A blended vial cannot by itself reveal which component produced an observed laboratory response.

For example, an experimental change could potentially reflect:

• GHK-Cu activity
• BPC-157 activity
• Thymosin beta-4 activity
• An interaction between components
• Experimental variability

Appropriate controls are required before assigning mechanism.

Glow Blend Peptide Dosage Search Context

The phrase glow blend peptide dosage generally concerns human administration.

Protide Health does not provide human dosing guidance.

The listed quantities represent vial contents:

• GHK-Cu: 50mg
• BPC-157: 10mg
• TB-500: 10mg
• Total: 70mg

These values are not recommended doses.

No guidance is provided for:

• Human injection
• Administration frequency
• Reconstitution for human use
• Treatment cycles
• Body-weight calculations
• Injury protocols
• Cosmetic protocols
• Topical application

Qualified laboratories should establish experimental concentrations according to validated study design.

Peptide Glow Blend Research Terminology

The search phrase peptide glow blend refers to the same three-component formulation.

It is important to distinguish the molecular sizes and structures involved:

GHK-Cu

A three-amino-acid copper complex.

BPC-157

A 15-amino-acid synthetic peptide.

TB-500 / Thymosin Beta-4

A 43-amino-acid N-acetylated actin-binding peptide.

These molecules differ substantially in:

• Size
• Structure
• Charge
• Molecular weight
• Biological targets
• Analytical behavior

They should not be treated as interchangeable.

Peptides Glow Blend & Copper-Associated Color

The blue or blue-white appearance of the Glow Blend is consistent with its GHK-Cu content.

Copper coordination can influence:

• Color
• Spectroscopy
• Charge state
• Molecular coordination
• Analytical behavior

The blue appearance is a physical characteristic of the copper-containing formulation and does not indicate biological potency.

Research Blend Design & Controls

Researchers studying the Glow Blend peptide may require several comparator groups to interpret results properly.

Potential experimental controls include:

• GHK-Cu alone
• BPC-157 alone
• Thymosin beta-4 alone
• GHK-Cu + BPC-157
• GHK-Cu + thymosin beta-4
• BPC-157 + thymosin beta-4
• Full three-component blend
• Vehicle control

This approach can help separate individual effects from combination effects.

The presence of all three compounds in one vial does not prove synergy.

Related Protide Health Research Products

Researchers comparing modified neuropeptide formulations may review the Semax + Selank N-Acetyl Amidate Blend for a mechanistically distinct two-peptide research system.

The NAD+ + MOTS-c + 5-Amino-1MQ Mitoprime Blend provides a separate metabolic and mitochondrial research formulation.

Researchers may also compare the Klow Blend GHK-Cu + KPV + BPC-157 + TB-500 for a related multi-component blend that additionally incorporates KPV.

These products should not be considered interchangeable with the Glow Blend peptide.

Research Format & Storage

Protide Health supplies the Glow Blend peptide as:

• GHK-Cu: 50mg
• BPC-157: 10mg
• TB-500: 10mg
• Total Quantity: 70mg
• Form: Lyophilized powder
• Vial Size: 3mL
• Purity: 99%
• Testing: HPLC-MS verified; third-party tested
• Appearance: Blue to blue-white
• Solubility: Soluble in water

Storage specifications:

• Store at ≤6°C
• Keep sealed
• Protect from heat
• Protect from direct light
• Protect from moisture

These statements describe laboratory storage characteristics only.

Research Limitations

Several limitations should be considered when interpreting Glow Blend peptide research:

• The formulation contains three chemically distinct peptides.
• The blend is not one established pharmacological entity.
• Co-formulation does not establish synergy.
• GHK-Cu database identity varies according to copper coordination representation.
• CAS 49557-75-7 belongs to metal-free GHK, not canonical prezatide copper.
• BPC-157 evidence remains dominated by preclinical research.
• Thymosin beta-4 research should be distinguished from shorter TB-500 fragment products.
• Individual-component findings cannot automatically be assigned to the complete blend.
• Animal findings cannot establish equivalent human effects.
• Existing human safety evidence for emerging peptide blends is limited.
• The 70mg quantity represents vial contents, not a human dose.
• The Protide Health product is not an FDA-approved therapeutic or cosmetic product.

For these reasons, the Glow Blend peptide is supplied strictly for qualified laboratory research.

Literature & Citation Index

The Tripeptide-Copper Complex Glycyl-L-Histidyl-L-Lysine-Cu2+ Stimulates Matrix Metalloproteinase-2 Expression by Fibroblast Cultures

Year: 2000
PMID: 11045606
DOI: 10.1016/S0024-3205(00)00803-1
Research Context: GHK-Cu, dermal fibroblasts, MMP-2, TIMP-1, TIMP-2, extracellular matrix, and matrix remodeling.

BPC 157 and Blood Vessels

Year: 2014
PMID: 23782145
DOI: 10.2174/13816128113199990421
Research Context: BPC-157, vascular responses, VEGF, FAK, nitric oxide, endothelial biology, and preclinical vascular models.

Thymosin Beta 4 Binds Actin in an Extended Conformation and Contacts Both the Barbed and Pointed Ends

Year: 1997
PMID: 9153421
DOI: 10.1021/bi970185v
Research Context: Thymosin beta-4, G-actin binding, 1:1 complex formation, actin sequestration, and polymerization research.

Researchers can review broader GHK-Cu, BPC-157 and thymosin beta-4 literature indexed by PubMed for additional peer-reviewed research.

Frequently Asked Questions

What is the Glow Blend peptide?

The Glow Blend peptide is a three-component laboratory research formulation containing GHK-Cu 50mg, BPC-157 10mg, and TB-500 / thymosin beta-4 10mg.

What does the Glow Blend contain?

Each vial contains:

• GHK-Cu 50mg
• BPC-157 10mg
• TB-500 10mg
• Total 70mg

What are the Glow Blend peptides?

The Glow Blend peptides are GHK-Cu, BPC-157, and full-length thymosin beta-4.

What is GHK-Cu?

GHK-Cu is the copper complex of the tripeptide Gly-His-Lys.

What is the correct CAS number for GHK-Cu?

CAS 49557-75-7 corresponds to metal-free GHK. PubChem associates prezatide copper / Copper Tripeptide-1 with CAS 89030-95-5.

What is BPC-157?

BPC-157 is a synthetic 15-amino-acid peptide with the sequence:

GEPPPGKPADDAGLV

What is TB-500 in this Glow Blend?

The supplied specification describes TB-500 as full-length N-acetylated thymosin beta-4, a 43-amino-acid actin-binding peptide.

Why is Glow Blend blue?

The blue to blue-white appearance is associated with the copper-containing GHK-Cu component.

What are Glow Blend peptide benefits?

Individual components have been investigated in extracellular-matrix, vascular, cellular, and actin-related systems, but established human Glow Blend peptide benefits have not been demonstrated for the complete formulation.

Is Glow peptide blend one peptide?

No. The Glow peptide blend contains three separate peptide research compounds.

What is the Glow Blend peptide dosage?

Protide Health does not provide a human Glow Blend peptide dosage. The 70mg total describes vial contents only.

Do the three peptides work synergistically?

Synergy has not been established simply by combining them. Controlled experiments would be required to demonstrate a synergistic interaction.

What purity does Protide Health specify?

Protide Health specifies 99% purity, with HPLC-MS verification and third-party testing.

Is Glow Blend intended for human use?

No. It is supplied solely for copper-peptide, vascular, cytoskeletal, cellular, molecular, biochemical, analytical, in-vitro, and qualified preclinical research.

Laboratory Terms & Compliance

Laboratory Research Use Only

The Glow Blend peptide is supplied exclusively for laboratory research, analytical testing, copper-peptide studies, vascular-signaling research, cytoskeletal investigation, biochemical experimentation, cellular models, in-vitro studies, and qualified preclinical experimentation.

It is not intended for human or veterinary consumption, medical use, wound treatment, injury recovery, skin treatment, cosmetic use, anti-aging treatment, bodybuilding, athletic-performance enhancement, injection, topical human use, or clinical administration.

No human dosage, injection schedule, topical protocol, reconstitution instructions for administration, injury-treatment protocol, cosmetic-use instructions, body-weight calculation, or human-use preparation guidance is provided.

The purchaser is responsible for appropriate laboratory handling, storage, and use under applicable institutional, federal, state, and local requirements.

For research use only.